London RS, Murphy L, Kitlowski KE, et al. Efficacy of alphatocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400–404.
30.
Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005;112:466–469.
31.
Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of the premenstrual syndrome—a review. Br J Obstet Gynaecol 1990;97:847–852.
32.
Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375–1781.
33.
Dell DL, Svec C. The PMDD phenomenon: breakthrough treatments for premenstrual dysphoric disorder (PMDD) and extreme premenstrual syndrome (PMS). New York: McGraw-Hill, 2002.
34.
Berger D, Schaffner W, Schrader E, et al. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet 2000;264:150–153.
35.
Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;322:134–137.
36.
Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 2000;9:315–320.
37.
Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 2003;18:191–195.
38.
Meier B, Berger D, Hoberg E, et al. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 2000;7:373–381.
39.
Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. BJOG 2000;107:870–876.
40.
Tamborini A, Taurelle R. Value of standardized ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome). Rev Fr Gynecold Obstet 1993;88:447–457.
41.
Ashton AK. Antidepressant-induced sexual dysfunction and ginkgo biloba. Am J Psychiatry 2000;157:836–837.
42.
Saldeen P, Saldeen T. Women and omega-3 fatty acids. Obstet Gynecol Surv 2004;59:722–730; quiz 745–746.
43.
Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 2007;12:207–227.
44.